Published • loading... • Updated
CRISPR makes prostate cancer vulnerable to immunotherapy
The experimental CRISPR Cas13 approach restored an immune signal in mice and made checkpoint therapy more effective, with no detectable off-target effects.
Summary by Science Daily
2 Articles
2 Articles
Gene editing may help the immune system find prostate cancer
Researchers at Duke and Rochester universities used gene editing to repair a molecular defect that helps prostate tumors evade immune detection; in mice, the experimental treatment sharply improved immunotherapy, but remains preclinical
·Tel Aviv-Yafo, Israel
Read Full Article
CRISPR makes prostate cancer vulnerable to immunotherapy
Scientists used CRISPR to make prostate cancer cells easier for the immune system to detect and destroy. The experimental treatment dramatically improved the effects of immunotherapy in mice and may offer hope for other hard-to-treat tumors.
·Encinitas, United States
Read Full ArticleCoverage Details
Total News Sources2
Leaning Left1Leaning Right0Center1Last UpdatedBias Distribution50% Left, 50% Center
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
50% Center
L 50%
C 50%
Factuality
To view factuality data please Upgrade to Premium
